PRECISION ENGINEERED MOLECULAR ASSAYS
BioGene designs and validates high sensitivity & specificity molecular assays, specifically optimised for deployment using the CENOS™ platform.
Our advanced in-silico pipeline models primer and probe hybridisation, across genetically diverse pathogens, including highly heterogeneous viruses, enabling precise multiplex detection.
VALIDATED PERFORMANCE
- Sensitive: ≤5 copies per reaction sensitivity
- Performance Driven: detects <1,000 genomes per swab or ml of blood
- Xtraction Free: direct detection from crude samples — no extraction required
- High Specificity: tested against unrelated high-titre pathogens
- Multiplex Detection: supports differential testing for blood-borne and respiratory threats
We design, validate, and deploy new assays within 8 weeks of sequence release, under our ISO 13485 validated processes.
We can port and optimise existing assays onto the CENOS™ platform, aligning performance with our proprietary system architecture.
Deployed beyond the laboratory — into field and satellite environments at the Point-of-Decision.
ASSAY SUPPLY FORMATS
Assays currently listed in the BioGene assay menu are supplied as a standard liquid master mix.
Where required, assays can also be provided in the following formats:
- Lyophilised directly in the CENOS vessel
- Lyophilised 10-reaction vial format
Alternative formats are available on request, but all are subject to commercial agreement and minimum assay quantities for specific assays.
We also provide a complete assay design and validation service for CENOS-compatible assays.
Please enquire for further details.